AB-CHFUPYCA

AB-CHFUPYCA

AB-CHFUPYCA
Systematic (IUPAC) name
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1H -pyrazole-5-carboxamide
CAS Registry Number  Y
Chemical data
Formula C22H29FN4O2
Molecular mass 400.50 g/mol

AB-CHFUPYCA is a compound that was first identified as a component of synthetic cannabis products in Japan in 2015.[1] The pharmacological properties of this compound have not been formally studied or reported in the scientific literature, but its discovery in recreational drug products suggests that it is intended be a cannabinoid agonist. Although AB-CHFUPYCA contains structural elements common to the synthetic cannabinoid designer drugs AB-PINACA and AB-FUBINACA, it can also be considered an analog of the traditional pyrazole cannabinoid receptor 1 antagonist rimonabant.

See also

References

  1. ^ Uchiyama, N.; Asakawa, K.; Kikura-Hanajiri, R.; Tsutsumi, T.; Hakamatsuka, T. (2015). "A new pyrazole-carboxamide type synthetic cannabinoid AB-CHFUPYCA [N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1H-pyrazole-5-carboxamide] identified in illegal products". Forensic Toxicology.